Netflix enters the final stretch before its July 16 print having given back a sliver of last week's sharp recovery, with the real story now shifting from positioning to the yawning gap between where the stock trades and what the Street thinks it's worth.
The bounce has stalled. After snapping back from a late-June low near $71 to close at $77.65 last week, NFLX has drifted back to $76.18 — a gain of just 0.2% on the day but still up 6.7% on the week as the prior bounce carries through the measurement window. The stock remains roughly 30% below its April pre-earnings highs near $108 and is still down 7.3% over the past month. The recovery looks increasingly like a consolidation rather than a sustained re-rating.
Short sellers have continued their quiet retreat. SI % of free float runs at 2.4%, down 2.6% on the week and off from the late-June peak when positions approached 103 million shares. The borrow market adds no urgency to the picture: availability is effectively uncapped, with over 3 billion shares available to lend against roughly 100 million currently shorted — the lending pool is among the loosest of any major Nasdaq name. Cost to borrow edged up 13% on the week to 0.44%, but that is noise at a level so low it barely registers. The ORTEX short score has drifted gently lower all week, now at 32.0, confirming that bearish conviction is easing rather than building. Options positioning is equally calm — the put/call ratio of 0.80 sits marginally below its 20-day average of 0.82, with a z-score of -0.38. There is no sign of hedging pressure or directional conviction either way ahead of earnings.
The more interesting tension is on the Street. Consensus remains firmly bullish — the mean analyst target is $113.49, implying roughly 49% upside from current levels. Bernstein's Laurent Yoon moved this morning, trimming his target from $110 to $100 while keeping an Outperform rating. That is a notable trim from a bellwether name published on earnings eve, though the direction of travel has been consistent since April: most post-Q1 updates saw analysts shave targets while holding positive ratings, reflecting the stock's sharp decline rather than any fundamental deterioration in the bull thesis. The bull case centres on advertising monetisation gaining traction, international expansion runway, and demonstrated operating leverage — Q1 2026 delivered 18% operating income growth on 14% revenue gains. The bear case is more macro in nature: ad spend sensitivity, subscriber growth opacity, and content cost competition. Valuation multiples have compressed meaningfully over 30 days, with the trailing P/E down from roughly 24x to 20.9x and price-to-book falling from 10.4x to 8.9x — the de-rating has been orderly but persistent.
Insider activity is worth a note. The 90-day net is a large net sale: founder and Chairman Reed Hastings sold just over 386,000 shares in early June for roughly $33 million. Co-CEOs Greg Peters and Ted Sarandos both sold in early May. The trades carry low significance scores (2-3 out of 10) and appear to be programmatic plan sales rather than discretionary liquidations, but the cluster of C-suite selling near the $85–$89 range — well above the current print — is a datapoint the market will not ignore.
The July 16 report is now the only thing that matters. Historically, the two most recent Q1 prints both produced sharp negative reactions — the stock fell more than 9.5% and 12% respectively on the day. The earnings history here shows the pattern of outsized negative day-one moves followed by continued weakness over five days. Whether the 30% drawdown already in the price changes that dynamic is the central question heading into next week.
See the live data behind this article on ORTEX.
Open NFLX on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
